Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
As of this writing, retatrutide is in late-stage clinical trials but has not received FDA approval
It may also lead to some irritability or tearfulness, especially between doses or after the effects wear off
GLP-1 patients who experience nausea or vomiting are already at risk for dehydration
Cleft Lip Repair, Primary Bilateral Before & After 10 Annual visits in the 4-6 year range center around speech
Mounjaro/Zepbound (tirzepatide), approved dual GLP-1/GIP agonist for type 2 diabetes and obesity Recent Highlights: In April 2026, the FDA approved orforglipron (Foundayo), making it one of the first oral GLP-1 pills that can be taken any time of day and that has no food or water restrictions
US$ 24.91
US$ 25.85
US$ 28.04
